JP Morgan Chase
KITE

JP Morgan Chase’s Kite Pharma, Inc. KITE Stock Holding History

JP Morgan Chase’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-30,000
Closed -$1.38M – 5128
2016
Q1 		$1.38M Buy
+30,000
New +$1.45M ﹤0.01% 2902

JP Morgan Chase's KITE Position: Q4 2017 in Review

JP Morgan Chase sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,528,805 shares — an estimated $275M sold.

JP Morgan Chase first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $275M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • JP Morgan Chase reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • JP Morgan Chase sold 1,528,805 Kite Pharma, Inc. shares in Q4 2017, an estimated $275M.
  • JP Morgan Chase first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
  • JP Morgan Chase's Kite Pharma, Inc. position peaked at $275M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.